Holen Sie sich die Stockscreener-App
13.06
0.23%
-0.11
Schlusskurs vom Vortag:
$12.95
Offen:
$13.11
24-Stunden-Volumen:
30,221
Relative Volume:
0.02
Marktkapitalisierung:
$1.67B
Einnahmen:
$3.31B
Nettoeinkommen (Verlust:
$98.90M
KGV:
-21.30
EPS:
-0.6131
Netto-Cashflow:
$195.60M
1W Leistung:
-8.24%
1M Leistung:
-13.87%
6M Leistung:
-41.56%
1J Leistung:
-45.32%
1-Tages-Spanne:
$12.90
$13.23
1-Wochen-Bereich:
$12.72
$14.19
52-Wochen-Spanne:
$12.25
$24.60
Surgery Partners Inc Stock (SGRY) Company Profile
Firmenname
Surgery Partners Inc
Sektor
Branche
Telefon
615-234-5900
Adresse
340 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY vs HCA, THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
12.91 | 1.72B | 3.31B | 98.90M | 195.60M | -0.6131 |
|
HCA
Hca Healthcare Inc
|
536.09 | 120.23B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
234.91 | 20.65B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.80 | 12.82B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
208.02 | 12.18B | 4.11B | 239.98M | 193.10M | 4.12 |
|
UHS
Universal Health Services Inc
|
184.72 | 11.39B | 16.08B | 1.20B | 1.06B | 17.82 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Fortgesetzt | JP Morgan | Neutral |
| 2025-07-28 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-16 | Eingeleitet | BofA Securities | Buy |
| 2024-10-14 | Eingeleitet | UBS | Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-06-28 | Eingeleitet | Macquarie | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-11-14 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-06-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-05-12 | Eingeleitet | Mizuho | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-11-23 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-06-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-11-30 | Eingeleitet | Barclays | Overweight |
| 2021-11-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-11-01 | Eingeleitet | JP Morgan | Neutral |
| 2021-10-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-06-23 | Fortgesetzt | Stifel | Hold |
| 2020-09-17 | Bestätigt | The Benchmark Company | Buy |
| 2020-04-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-03-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-01-14 | Bestätigt | The Benchmark Company | Buy |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-09-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-06-28 | Hochstufung | Stifel | Sell → Hold |
| 2018-01-30 | Bestätigt | The Benchmark Company | Buy |
| 2017-11-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-08-09 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-08-09 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2017-08-09 | Herabstufung | Stifel | Hold → Sell |
| 2017-04-24 | Bestätigt | Stifel | Hold |
| 2017-03-10 | Herabstufung | Stifel | Buy → Hold |
| 2017-01-31 | Eingeleitet | The Benchmark Company | Buy |
| 2016-06-10 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-03-14 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-10-27 | Eingeleitet | Stifel | Buy |
| 2015-10-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-10-26 | Eingeleitet | Raymond James | Strong Buy |
Alle ansehen
Surgery Partners Inc Aktie (SGRY) Neueste Nachrichten
Surgery Partners at Barclays Healthcare Conference: Strategic Plans Amid Challenges - Investing.com
Deals tracker: Elsevier to acquire Mytonomy - Modern Healthcare
Activist Ortelius pushes for board changes, asset sales at Surgery Partners - Seeking Alpha
Activist investor calls for Surgery Partners leadership change By Investing.com - Investing.com India
Ortelius Capital Management recently proposed a series of strategic adjustments for Surgery Partners, Inc., including a comprehensive overhaul of the board structure, the introduction of a new management team, and a systematic evaluation of the company’s - Bitget
Ortelius Delivers Open Letter To Surgery Partners Stockholders - TradingView
Ortelius Delivers Open Letter to Surgery Partners Stockholders - The Joplin Globe
Activist urges Surgery Partners to sell hospitals and raise billions - Stock Titan
Surgery Partners to Present at Barclays Healthcare Conference - National Today
Precision Trading with Surgery Partners Inc. (SGRY) Risk Zones - Stock Traders Daily
Surgery Partners, Inc. $SGRY Stock Position Decreased by Gabelli Funds LLC - MarketBeat
Surgery Partners’ Webb sells $28,653 in shares By Investing.com - Investing.com India
Burkhalter, Surgery Partners CHRO, sells $105k in shares By Investing.com - Investing.com India
William Trenton Webb Sells 1,794 Shares of Surgery Partners (NASDAQ:SGRY) Stock - MarketBeat
Marissa Brittenham Sells 8,785 Shares of Surgery Partners (NASDAQ:SGRY) Stock - MarketBeat
David Doherty Sells 14,574 Shares of Surgery Partners (NASDAQ:SGRY) Stock - MarketBeat
Jennifer Baldock Sells 10,082 Shares of Surgery Partners (NASDAQ:SGRY) Stock - MarketBeat
Surgery Partners (NASDAQ:SGRY) CEO Sells $158,060.98 in Stock - MarketBeat
Baldock of Surgery Partners sells $138k in shares - Investing.com
Surgery Partners CFO Doherty sells $201,704 in shares By Investing.com - Investing.com UK
Surgery Partners CFO Doherty sells $201,704 in shares - Investing.com
Baldock of Surgery Partners sells $138k in shares By Investing.com - Investing.com UK
Surgery Partners, Inc. to Present at Upcoming Investor Conference - marketscreener.com
Outpatient Care Q4 2025: Mixed Earnings, Surgery Partners Revenue UpNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Outpatient & Specialty Care Stocks Q4 Highlights: Surgery Partners (NASDAQ:SGRY) - Finviz
Surgery Partners, Inc. (NASDAQ:SGRY) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Surgery Partners, Inc. Stock Plummets to New 52-Week Low at $12.25 - Markets Mojo
GABELLI & Co INVESTMENT ADVISERS INC. Lowers Holdings in Surgery Partners, Inc. $SGRY - MarketBeat
Surgery Partners Faces Weak Start with 21.85% Gap Down Amid Market Concerns - Markets Mojo
Day Trade: Is Surgery Partners Inc affected by consumer sentimentJuly 2025 Fed Impact & Stock Market Timing Techniques - baoquankhu1.vn
Assessing Surgery Partners (SGRY) Valuation After Recent Share Price Weakness And Undervalued Narrative - Sahm
TD Cowen Lowers Surgery Partners (NASDAQ:SGRY) Price Target to $20.00 - MarketBeat
SGRY Stock: TD Cowen Lowers Price Target to $20.00, Maintains Bu - GuruFocus
Analyst Expectations For Surgery Partners's Future - Benzinga
UBS Group Issues Pessimistic Forecast for Surgery Partners (NASDAQ:SGRY) Stock Price - MarketBeat
UBS Maintains 'Buy' Rating for Surgery Partners (SGRY), Lowers P - GuruFocus
UBS Adjusts Price Target on Surgery Partners to $21 From $29, Maintains Buy Rating - marketscreener.com
SGRY: Mizuho Lowers Price Target to $17, Maintains Outperform Ra - GuruFocus
Surgery Partners (NASDAQ:SGRY) Price Target Cut to $17.00 by Analysts at Mizuho - MarketBeat
Surgery Partners acquires dialysis access provider for $6B market By Investing.com - Investing.com Canada
Jefferies Maintains Buy on Surgery Partners (SGRY) March 2026 - Meyka
ZIEGLER ADVISES PREFERRED VASCULAR GROUP ON ITS ACQUISITION BY SURGERY PARTNERS - Finviz
Benchmark cuts Surgery Partners stock price target on weak guidance By Investing.com - Investing.com Canada
Jefferies cuts Surgery Partners stock price target on earnings reset By Investing.com - Investing.com Canada
Custom Surgical Partners & Ambulatory Strategies Unite: Decades of ASC Expertise - Newswise
Surgery Partners, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - marketscreener.com
Surgery Partners, Inc. Shareholders Are Encouraged to Reach - GlobeNewswire
RBC Cuts Price Target on Surgery Partners to $20 From $31, Keeps Outperform Rating - marketscreener.com
Surgery Partners, Inc. (NASDAQ:SGRY) Q4 2025 Earnings Call Transcript - Insider Monkey
Surgery Partners (SGRY -12%): Weak Guidance, Q4 EBITDA Miss Drive Sell-Off - Trefis
SGRY Financials: Income Statement, Balance Sheet & Cash Flow | Surgery Partners Inc - Stock Titan
Finanzdaten der Surgery Partners Inc-Aktie (SGRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.16%
0.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):